CLINICAL ASPECTS OF THYROID DYSFUNCTION DURING COMBINED THERAPY FOR BREAST CANCER
Authors
Azimova A. Makhbuba, Nasirova K. Khurshida
Share
Annotation
Breast cancer is among the most prevalent cancers affecting women and often necessitates a multifaceted treatment approach. However, combined treatment methods such as chemotherapy and radiotherapy can negatively impact thyroid gland (TG) function, potentially causing hormonal imbalances. These thyroid issues can deteriorate a patient's general health, lower their ability to tolerate treatment, and possibly affect the effectiveness of therapy. In Uzbekistan, this area has not been thoroughly explored, emphasizing the importance of a detailed evaluation of thyroid function in women with BC.
Keywords
Authors
Azimova A. Makhbuba, Nasirova K. Khurshida
Share
References:
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Shering SG, Zbar AP, Moriarty M, McDermott EW, O'Higgins NJ, Smyth PP. Thyroid disorders and breast cancer. Eur J Cancer Prev 1996; 5: 504-506.
3. Giani C, Fierabracci P, Bonacci R, Gigliotti A, Campani D, De Negri F. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 1996; 81: 990-994.
4. Clarke R, Dickson RB, Brunner N. The process of malignant progression in human breast cancer. Ann Oncol 1990; 1: 401-407.
5. Gogas J, Kouskos E, Tseleni-Balafouta S, Markopoulos C, Revenas K, Gogas G. Autoimmune thyroid disease in women with breast carcinoma. Eur J Surg Oncol 2001; 27: 626-630.
6. Turken O, NarIn Y, DemIrbas S, Onde ME, Sayan O, KandemIr EG. Breast cancer in association with thyroid disorders. Breast Cancer Res 2003; 5: 110-113.
7. Perry M, Goldie DJ, Self M. Thyroid function in patients with breast cancer. Ann R Coll Surg Engl 1978; 60: 290-293.
8. Smyth PP. The thyroid, iodine and breast cancer. Breast Cancer Res 2003; 5: 235-238.
9. Vorherr H. Thyroid disease in relation to breast cancer. Klin Wochenschr 1978; 56: 1139-1145.
10. Saraiva P, Figueiredo N, Padovani C, Brentani M, Nogueira C. Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 2005; 38: 761-765.
11.Smyth P. Thyroid disease and breast cancer. J Endocrinol Invest 1993; 16: 396-401.
12. Agarwal DP, Soni TP, Sharma OP, Sharma S. Synchronous malignancies of breast and thyroid gland: a case report and review of literature. J Cancer Res Ther 2007; 3: 172-173.
13. Fierabracci P, Pinchera A, Campani D, Pollina LE, Giustarini E, Giani C. Association between breast cancer and autoimmune thyroid disorders: no increase of lymphocytic infiltrates in breast malignant tissues. J Endocrinol Invest 2006; 29: 248-251.
14. Giustarini E, Pinchera A, Fierabracci P, Roncella M, Fustaino L, Mammoli C. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 2006; 154: 645-649.
15. Sabitha, Suneetha, Mohanty S, Rao P. Serum anti-TPO levels in benign and malignant breast tumors. Indian J Clin Biochem 2009; 24: 266-268.
16. Ali A, Mir MR, Bashir S, Hassan T, Bhat SA. Relationship between the levels of serum thyroid hormones and the risk of breast cancer. J Biol Agric Health 2011; 1: 56-59.
17.Smyth PP, Shering SG, Kilbane MT, Murray MJ, McDermott EW, Smith DF. Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 1998; 83: 2711-2716. Motie/Taheri/Noorian 8628 Biomed Res 2017 Volume 28 Issue 20
18. Ditsch N, Liebhardt S, Von Koch F, Lenhard M, Vogeser M, Spitzweg C. Thyroid function in breast cancer patients. Anticancer Res 2010; 30: 1713-1717.
19. Michalaki V, Kondi-Pafiti A, Gennatas S, Antoniou A, Primetis H, Gennatas C. Breast cancer in association with thyroid disorders. J Buon 2009; 14: 425-428.
20. Wang G, Chen X-S, Mao Y, Li Y-F, Chen W-G, Shen K-W. Patients with breast cancer have a higher level of serum free thyroxine (T4) compared with those with benign breast diseases. Tumor 2014; 34: 366-369.
21. Takatani O, Okumoto T, Kosano H, Nishida M, Hiraide H, Tamakuma S. Relationship between the levels of serum thyroid hormones or estrogen status and the risk of breast cancer genesis in Japanese women. Cancer Res 1989; 49: 3109-3112.
22. Kuijpens JL, Nyklictek I, Louwman MW, Weetman TA, Pop VJ, Coebergh JW. Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid 2005; 15: 1253-1259.
23. Saraiva P, Figueiredo N, Padovani C, Brentani M, Nogueira C. Profile of thyroid hormones in breast cancer patients. Brazil Med Biol Res 2005; 38: 761-765.
24. Rose DP, Davis TE. Plasma triiodothyronine concentrations in breast cancer. Cancer 1979; 43: 1434-1438.
25. Tosovic A, Bondeson AG, Bondeson L, Ericsson UB, Malm J, Manjer J. Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women. Breast Cancer Res 2010; 12: 33.
26. Cengiz O, Bozkurt B, Unal B, Yildirim O, Karabeyoglu M, Eroglu A. The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. J Surg Oncol 2004; 87: 19-25.
27. Tosovic A, Becker C, Bondeson AG, Bondeson L, Ericsson UB, Malm J. Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer 2012; 131: 2126-2133.
28. Lemaire M, Baugnet-Mahieu L. Thyroid function in women with breast cancer. Eur J Cancer Clin Oncol 1986; 22: 301-307.
Other articles of the issue
